RXRX

RXRX

USD

Recursion Pharmaceuticals Inc. Class A Common Stock

$5.000-0.200 (-3.846%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$5.200

Máximo

$5.320

Mínimo

$4.970

Volume

57.15M

Fundamentos da empresa

Capitalização de mercado

2.2B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

39.05M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $3.79Atual $5.000Máximo $12.36

Notícias relacionadas

GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following

Ver mais
Recursion to Participate in Upcoming Investor Conferences
GlobeNewswire

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and

Ver mais
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Reuters

Buybacks take backseat as AI drives record US capex spending

Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.

Ver mais
Buybacks take backseat as AI drives record US capex spending

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.